05-15-2019 07:41 AM CET - Health & Medicine
Print

Macular Degeneration Treatment Market Professional and In-Depth Analysis by 2027 with Key Player Insights: Bayer AG, Neurotech Pharmaceuticals, Ophthotech Corporation, F. Hoffmann-La Roche, StemCells, Pfizer, Sanofi

Press release from: The Insight Partners
The Insight Partners
The Insight Partners


Macular Degeneration Treatment Market is anticipated to grow in the forecast period owing to driving factors such as increasing population of geriatric patients, rising patient population suffering from Macular Degeneration, growing awareness about drugs for treating AMD, introduction on new therapies, improving healthcare as well as healthcare infrastructure, and increase in prevalence and incidence of retinal disorders. Nevertheless, continuous pressure from some key players in binding the usage of different drugs for wet AMD and intrusive administration methods is expected to restrict the market growth during the forecast period.

Macular Degeneration Treatment Market to 2027 - Global Analysis and Forecasts by Disease Indication (Dry Age-related macular degeneration treatment, Wet age-related macular de-generation treatment, Others); Drug Class (Anti-Vascular endothelial growth factor, Others); End User (Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals)

Macular Degeneration is a medical condition that may result in blurred or no vision in the center of the visual field. There may be no symptoms at times at the beginning of macular degeneration, but eventually some people experience a gradual worsening of vision that may affect both or one eye.

Get Sample report at www.theinsightpartners.com/sample/TIPRE00004433

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Macular Degeneration Treatment Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Macular Degeneration Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Macular Degeneration Treatment Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Macular Degeneration Treatment Market in these regions.

The "Global Macular Degeneration Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Macular Degeneration Treatment Market with detailed market segmentation by Disease Indication, Drug Class, End User and geography. The global Macular Degeneration Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Macular Degeneration Treatment Market players and offers key trends and opportunities in the market.

The global Macular Degeneration Treatment Market is segmented on the basis of Disease Indication, Drug Class and End User. Based on Disease Indication the market is segmented into Dry Age-related macular degeneration treatment, Wet age-related macular de-generation treatment and Others. Based on Drug Class the market is segmented into Anti-Vascular endothelial growth factor and Others. Based on End User the market is segmented into Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals.

Browse Complete Report at www.theinsightpartners.com/reports/macular-degeneration-t...

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Macular Degeneration Treatment Market - By Disease Indication
1.3.2 Macular Degeneration Treatment Market - By Drug Class
1.3.3 Macular Degeneration Treatment Market - By End User
1.3.4 Macular Degeneration Treatment Market - By Region
1.3.4.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. MACULAR DEGENERATION TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. MACULAR DEGENERATION TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

Have queries? Ask us at www.theinsightpartners.com/inquiry/TIPRE00004433

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: www.theinsightpartners.com

This release was published on openPR.
News-ID: 1739439 • Views: 137
More releasesMore releases

You can edit or delete your press release here: